[Antihepatotoxic influence of silymarin on galactosamine hepatitis in the rat].
D000410:Alanine Transaminase / Q000097:blood; D000438:Alcohols / Q000627:therapeutic use; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D004195:Disease Models, Animal; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D005688:Galactosamine / Q000494:pharmacology*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000187:drug effects; D011517:Prothrombin Time; D051381:Rats; D013385:Succinate Dehydrogenase / Q000097:blood
D000438:Alcohols; D005419:Flavonoids; D005688:Galactosamine; D007770:L-Lactate Dehydrogenase; D013385:Succinate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Zur antihepatotoxischen Wirksamkeit von Silymarin bei der Galactosamin-Hepatitis der Ratte.